Figure 3
Figure 3. PDGF but not VEGF in the CLL-CM is able to activate MSC PDGFR. (A) Variable levels of PDGF and VEGF were detected in CLL-CM. The line in each dot plot represents the mean level of detected growth factor. (B) RTK array analysis of CLL MSC stimulated by CLL-CM for 30 minutes in the presence or absence of neutralizing antibody to PDGF, VEGF, or both. RTK array analysis of CLL MSC was performed in the presence of either PDGF-AB or VEGF-A ligand. (C) Immunoblot analysis demonstrating the presence of PDGF-AB in CLL B cells. PDGF-AB was up-regulated when CLL B cells were cultured under hypoxic conditions after overnight culture in 3 of 4 patients tested. CLL 1-4, 4 CLL patient lysates used in the immunoblot. Four different CLL samples were run on separate gels and are shown. Each gel is shown in separate rectangle.

PDGF but not VEGF in the CLL-CM is able to activate MSC PDGFR. (A) Variable levels of PDGF and VEGF were detected in CLL-CM. The line in each dot plot represents the mean level of detected growth factor. (B) RTK array analysis of CLL MSC stimulated by CLL-CM for 30 minutes in the presence or absence of neutralizing antibody to PDGF, VEGF, or both. RTK array analysis of CLL MSC was performed in the presence of either PDGF-AB or VEGF-A ligand. (C) Immunoblot analysis demonstrating the presence of PDGF-AB in CLL B cells. PDGF-AB was up-regulated when CLL B cells were cultured under hypoxic conditions after overnight culture in 3 of 4 patients tested. CLL 1-4, 4 CLL patient lysates used in the immunoblot. Four different CLL samples were run on separate gels and are shown. Each gel is shown in separate rectangle.

Close Modal

or Create an Account

Close Modal
Close Modal